via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading
agency and financial media network dedicated to the North American
cannabis industry announces publication of an article
featuring Aleafia Health Inc. (TSX: ALEF) (OTC: ALEAF)
(FRA: ARAH). The company recently announced the
completion of its merger with Emblem Corp. Under the terms of the
agreement, Aleafia Health acquired all of Emblem’s common shares
and formed a new wholly-owned subsidiary that will keep the name
Emblem name. The completion of the merger marks a key milestone for
both companies as they work to build long-term shareholder value.
In this article, we will take a closer look at the implications
of the merger and why investors may want to take a closer look at
Aleafia Health following the transaction.
Click Here to Download Aleafia Health Inc.’s Investor
Presentation
Creating a New Leader
Aleafia Health’s merger with Emblem creates Canada’s largest
medical cannabis clinic with more than 60,000 patients with access
to unique cannabis oils, capsules and sprays. In addition, the
company’s three dedicated cultivation facilities provide an ample
cannabis supply to provinces, retailers and export markets. These
operations are already generating significant revenue under the
largest LP-to-LP supply agreement in the industry.
“The acquisition of Emblem rapidly accelerates the execution of
Aleafia Health’s strategy and positioning as a
vertically-integrated, diversified cannabis company with an
integrated, highly differentiated consumer ecosystem,” says Aleafia
Health CEO Geoffrey Benic. “Emblem’s product leadership in the
medical and adult-use sectors and highly coveted supply agreements
will perfectly complement our cannabis production and clinic
operations.”
During the third quarter of 2018, Emblem’s revenue grew 281
percent to $2.3 million with an industry-leading $10.67 of revenue
per gram equivalent. The company also reported a 20 percent
quarter-over-quarter increase in its patient population to over
4,800 active patients. On the product side, the company launched an
innovative oral dose-metered spray, Atmosphere, and its first
adult-use cannabis brand, Symbl.
Numerous Catalysts Ahead
Aleafia Health has been making tremendous progress on its own
initiatives apart from the Emblem merger. During the third quarter
of 2018, the company indicated that the fully-funded retrofitting
of its 160,000 sq. ft. Niagara greenhouse facility and outdoor
expansion was on schedule. Management anticipates that these
efforts will result in an annual production capacity of 98,000
kilograms, making it one of the larger licensed producers in
Canada.
In addition to improving production capacity, the company
continues to invest in patient education as a key differentiator.
The company has developed and implemented a proprietary training
program for all of its staff to help those with chronic medical
conditions that have failed first, second, and often, third line
approaches. The training program extends to both internal and
partner clinics to service a maximum amount of patients.
The company also continues to make waves in the medical cannabis
research space. With more than 60,000 patients, the company has
amassed one of the largest medical cannabis datasets in the world,
enabling researchers to validate cannabis sciences, product teams
to develop innovative new products, and management to build a
strong IP portfolio. In the third quarter, this division
contributed $612,000 to revenue.
Click Here to Download Aleafia Health Inc.’s Investor
Presentation
Looking Ahead
Aleafia Health Inc. (TSX: ALEF) (OTC: ALEAF) (FRA: ARAH) is
well positioned within Canada’s nascent cannabis industry following
its merger with Emblem. With robust patient growth, high margin
products, and growing revenue, investors may want to take a closer
look at the combined company ahead of several potential
catalysts.
For more information, visit the company’s website
at www.aleafiahealth.com.
Please follow the link to watch the full
interview: https://www.cannabisfn.com/aleafia-health-emblem-merger-creates-a-new-cannabis-leader/
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media
network dedicated to legal cannabis. We help marijuana businesses
attract investors, customers (B2B, B2C), capital, and media
visibility. Private and public marijuana companies and brands in
the US and Canada rely on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or
entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of
cannabis from the palm of your
hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the
Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment
advisor or broker-dealer. You should always consult with your own
independent legal, tax, and/or investment professionals before
making any investment decisions. The information provided
on http://www.cannabisfn.com (the ‘Site’) is either
original financial news or paid advertisements drafted by our
in-house team or provided by an affiliate. CannabisFN.com, a
financial news media and marketing firm enters into media buys or
service agreements with the companies that are the subject of the
articles posted on the Site or other editorials for advertising
such companies. We are not an independent news media
provider. We make no warranty or representation about the
information including its completeness, accuracy, truthfulness or
reliability and we disclaim, expressly and implicitly, all
warranties of any kind, including whether the Information is
complete, accurate, truthful, or reliable. As such, your use of the
information is at your own risk. Nor do we undertake any obligation
to update the items posted. CannabisFN.com received compensation
for producing and presenting high quality and sophisticated content
on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC,
which owns CannabisFN.com and CFN Media, has been hired to create
awareness. Please follow the link below to view our full disclosure
outlining our
compensation: http://www.cannabisfn.com/legal-disclaimer/
Frank Lane 206-369-7050 Flane@cannabisfn.com